DSpace logo
Please use this identifier to cite or link to this item: http://172.20.40.131:8080/jspui/handle/123456789/496
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPrakash, Sanjay-
dc.contributor.authorMakwana, Prayag-
dc.contributor.authorRathore, Chaturbhuj-
dc.contributor.authorDave, Ankit-
dc.date.accessioned2019-08-05T04:17:57Z-
dc.date.available2019-08-05T04:17:57Z-
dc.date.issued2016-09-
dc.identifier.urihttp://localhost:80/xmlui/handle/123456789/496-
dc.description.abstractSerotonin syndrome (SS) is an iatrogenic, druginduced clinical syndrome caused by serotoninergic hyperstimulation. SS may have protean manifestations and can mimic a variety of medical conditions. Herein, we describe three cases of febrile encephalopathy who were on serotonergic agents. All three cases fulfilled Hunter’s criteria for SS and responded to the removal of the offending agents and the administration of cyproheptadine. All three patients had abnormal cerebrospinal fluid (CSF) examinations (pleocytosis in three patients and increased protein in two patients) which returned to normal with therapy. We suggest that SS presenting as febrile encephalopathy may have transient CSF abnormalities. Severe SS is a medical emergency. Therefore, a trial of cyproheptadine can be given in patients fulfilling the SS criteria even in the presence of CSF abnormalities. In parallel, the patients should be investigated for other causes of febrile encephalopathy and CSF pleocytosis.en_US
dc.language.isoen_USen_US
dc.publisherNeurological Sciencesen_US
dc.subjectSerotonin Syndromeen_US
dc.subjectSerotonergic Agenten_US
dc.subjectAutonomic Dysfunctionen_US
dc.subjectClonusen_US
dc.subjectCyproheptadineen_US
dc.titleSerotonin Syndrome Presenting as Febrile Encephalopathy with CSF Pleocytosis: A Report of Three Casesen_US
dc.typeArticleen_US
Appears in Collections:Faculty Publications

Files in This Item:
File Description SizeFormat 
prakash2016 (1).pdf334.81 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.